Romulus Therapeutics is a precision immunology company developing next-generation antibody therapeutics designed to selectively eliminate pathogenic immune cell subsets. Our approach moves beyond cytokine blockade toward cellular precision, targeting disease-driving immune populations to enable durable immune reset. The company combines deep expertise in antibody therapeutics, immunology, and translational drug development.